The online version of this article (https://doi.org/10.1186/s12879-017-2873-z) contains supplementary material, which is available to authorized users.
To evaluate in vitro susceptibilities of aerobic and facultative Gram-negative bacterial (GNB) isolates from intra-abdominal infections (IAIs) to 12 selected antimicrobials in Chinese hospitals from 2012 to 2014.
Hospital acquired (HA) and community acquired (CA) IAIs were collected from 21 centers in 16 Chinese cities. Extended spectrum beta-lactamase (ESBL) status and antimicrobial susceptibilities were determined at a central laboratory using CLSI broth microdilution and interpretive standards.
From all isolated strains the Enterobacteriaceae (81.1%) Escherichia coli accounted for 45.4% and Klebsiella pneumoniae for 20.1%, followed by Enterobacter cloacae (5.2%), Proteus mirabilis (2.1%), Citrobacter freundii (1.8%), Enterobacter aerogenes (1.8%), Klebsiella oxytoca (1.4%), Morganella morganii (1.2%), Serratia marcescens (0.7%), Citrobacter koseri (0.3%), Proteus vulgaris (0.3%) and others (1.0%). Non- Enterobacteriaceae (18.9%) included Pseudomonas aeruginosa (9.8%), Acinetobacter baumannii (6.7%), Stenotrophomonas maltophilia (0.9%), Aeromonas hydrophila (0.4%) and others (1.1%). ESBL-screen positive Escherichia coli isolates (ESBL+) showed a decreasing trend from 67.5% in 2012 to 58.9% in 2014 of all Escherichia coli isolates and the percentage of ESBL+ Klebsiella pneumoniae isolates also decreased from 2012 through 2014 (40.4% to 26.6%), which was due to reduced percentages of ESBL+ isolates in HA IAIs for both bacteria. The overall susceptibilities of all 5160 IAI isolates were 87.53% to amikacin (AMK), 78.12% to piperacillin-tazobactam (TZP) 81.41% to imipenem (IMP) and 73.12% to ertapenem (ETP). The susceptibility of ESBL-screen positive Escherichia coli strains was 96.77%–98.8% to IPM, 91.26%–93.16% to ETP, 89.48%–92.75% to AMK and 84.86%–89.34% to TZP, while ESBL-screen positive Klebsiella pneumoniae strains were 70.56%–80.15% susceptible to ETP, 80.0%–87.5% to IPM, 83.82%–87.06% to AMK and 63.53%–68.38% to TZP within the three year study. Susceptibilities to all cephalosporins and fluoroquinolones were less than 50% beside 66.5% and 56.07% to cefoxitin (FOX) for ESBL+ Escherichia coli and Klebsiella pneumoniae strains respectively.
The total ESBL+ rates decreased in Escherichia coli and Klebsiella pneumoniae IAI isolates due to fewer prevalence in HA infections. IPM, ETP and AMK were the most effective antimicrobials against ESBL+ Escherichia coli and Klebsiella pneumoniae IAI isolates in 2012–2014 and a change of fluoroquinolone regimens for Chinese IAIs is recommended.
Additional file 1: Table S1. Bacterial identification and epidemiological status of isolates from intra-abdominal infections in China (2012–2014). (DOC 54 kb)12879_2017_2873_MOESM1_ESM.doc
Additional file 2: Figure S1. Sources of ESBL-screen positive Escherichia coli and Klebsiella pneumoniae IAI isolates from 2012 to 2014. The upper numbers indicate the total number of isolates and the grey areas and numbers in the grey areas of the bars indicate the percentage of ESBL+ strains. (TIFF 748 kb)12879_2017_2873_MOESM2_ESM.tif
Hoffmann C, Zak M, Avery L, Brown J. Treatment modalities and antimicrobial stewardship initiatives in the Management of Intra-Abdominal Infections. Antibiotics (Basel). 2016;5
Sharma D, Hayman K, Stewart BT, Dominguez L, Trelles M, Saqeb S, et al. Surgery for conditions of infectious etiology in resource-limited countries affected by crisis: the Medecins sans Frontieres operations Centre Brussels experience. Surg Infect. 2015;16:721–7. CrossRef
Boontham P, Soontomrak R. Intra-abdominal infections: prevalence and risk factors of ESBLs infections. J Med Assoc Thail. 2015;98:1097–103.
Edelsberg J, Berger A, Schell S, Mallick R, Kuznik A, Oster G. Economic consequences of failure of initial antibiotic therapy in hospitalized adults with complicated intra-abdominal infections. Surg Infect. 2008;9:335–47. CrossRef
Leistner R, Schroder C, Geffers C, Breier AC, Gastmeier P, Behnke M. Regional distribution of nosocomial infections due to ESBL-positive Enterobacteriaceae in Germany: data from the German National Reference Center for the Surveillance of Nosocomial Infections (KISS). Clin Microbiol Infect. 2015;21(255):e1–5.
Hara T, Sato T, Horiyama T, Kanazawa S, Yamaguchi T, Maki H. Prevalence and molecular characterization of CTX-M extended-spectrum beta-lactamase-producing Escherichia Coli from 2000 to 2010 in Japan. Jpn J Antibiot. 2015;68:75–84. PubMed
CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement. CLSI document M100-S24. Wayne, PA: Clinical and Laboratory Standards Institute;. 2014.
CLSI. Performance Standards for Antimicrobial Susceptibility. Testing; 22nd Informational Supplement M100-S22. Wayne, PA: Clinical and Laboratory Standards Institute. 2012.
Yang Q, Wang H, Chen M, Ni Y, Yu Y, Hu B, et al. Surveillance of antimicrobial susceptibility of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections in China: the 2002-2009 study for monitoring antimicrobial resistance trends (SMART). Int J Antimicrob Agents. 2010;36:507–12. CrossRefPubMed
Siu LK, Fung CP, Chang FY, Lee N, Yeh KM, Koh TH, et al. Molecular typing and virulence analysis of serotype K1 Klebsiella Pneumoniae strains isolated from liver abscess patients and stool samples from noninfectious subjects in Hong Kong, Singapore, and Taiwan. J Clin Microbiol. 2011;49:3761–5. CrossRefPubMedPubMedCentral
TT Q, Zhou JC, Jiang Y, Shi KR, Li B, Shen P, et al. Clinical and microbiological characteristics of Klebsiella Pneumoniae liver abscess in East China. BMC Infect Dis. 2015;15:161. CrossRef
China. MoHotPsRo. Management of the clinical application of antimicrobial agents (Ministry of Health Order No. 84). 2012.
Vatopoulos A. High rates of metallo-beta-lactamase-producing Klebsiella Pneumoniae in Greece--a review of the current evidence. Euro Surveill. 2008;13
Zhang R, Ichijo T, YY H, Zhou HW, Yamaguchi N, Nasu M, et al. A ten years (2000-2009) surveillance of resistant Enterobacteriaceae in Zhejiang Province, China. Microb Ecol Health Dis. 2012;23
Hu Y, Yang X, Qin J, Lu N, Cheng G, Wu N, et al. Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota. Nat Commun. 2013;4:2151. PubMed
Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the surgical infection society and the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:133–64. CrossRefPubMed
Lou Z, Qi Y, Qian X, Yang W, Wei Z. Emergence of Klebsiella Pneumoniae carbapenemase-producing Escherichia Coli sequence type 131 in Hangzhou, China. Chin Med J. 2014;127:528–31. PubMed
Chen S, Hu F, Xu X, Liu Y, Wu W, Zhu D, et al. High prevalence of KPC-2-type carbapenemase coupled with CTX-M-type extended-spectrum beta-lactamases in carbapenem-resistant Klebsiella Pneumoniae in a teaching hospital in China. Antimicrob Agents Chemother. 2011;55:2493–4. CrossRefPubMedPubMedCentral
- Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
e.Med Kampagnen-Visual, Mail Icon II